Xiaoqing Xu

3PUBLICATIONS
2CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Dec 02, 2022
Targeting CD89 on tumor-associated macrophages overcomes resistance to immune checkpoint blockade.

Lijun Xu, Bingyu Li, Chenyu Pi

|Feb 25, 2022
A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity.

Yan Feng, Kun Xie, Yanxin Yin

Pageof 1